UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer

被引:115
作者
Ockenga, J
Vogel, A
Teich, N
Keim, V
Manns, MP
Strassburg, CP
机构
[1] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[2] Univ Leipzig, Dept Med, Leipzig, Germany
关键词
D O I
10.1016/S0016-5085(03)00294-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Chronic pancreatitis and pancreatic adenocarcinoma are associated with alcohol abuse, consumption of tobacco smoke, and environmental aromatic hydrocarbon exposure. The role of genetic factors is incompletely defined. Uridine 5-diphosphate glucuronosyltransferases are phase 11 detoxifying enzymes capable of tobacco-borne toxicant inactivation and cellular protection. This study analyzes UGT1A7 gene polymorphisms in pancreatic diseases. Methods: Genomic DNA from northern German white patients with pancreatic adenocarcinoma (n = 52) and chronic pancreatitis (n = 146), as well as healthy blood donors (n = 235) was analyzed by UGT1A7-specific PCR, sequencing analysis, and temperature gradient gel electrophoresis. Pancreatic expression of UGT1A genes was identified by duplex reverse-transcription PCR. Results: Predominant expression of the UGT1A7 gene was identified in human pancreatic tissue. Pancreatic adenocarcinoma was associated with the low detoxification activity UGTIA7*3 allele, which combines the W208R, N129K, and R131K mutations (odds ratio [OR], 1.98; 95% confidence interval (CI], 1.24-3.14; P = 0.003). The association of UGT1A7*3 was especially strong in smokers with pancreatic carcinoma who were younger than 55 years (OR, 4.7; 95% Cl, P = 0.0009). Chronic pancreatitis was also associated with UGT1A7*3 (OR, 1.76; 95% Cl, 1.26-2.46; P = 0.0009). UGTIA7*3 was specifically associated with the subgroup of patients with alcoholic pancreatitis, of whom 89% were smokers (OR, 2.24; 95% Cl, 1.46-3.43; P = 0.0001) but was not associated with the nonalcoholic pancreatitis subgroup. Conclusions: The UGT1A7 gene is predominantly expressed in human pancreas. The low detoxification activity UGTIA7*3 allele is identified as a novel risk factor of pancreatic diseases defining the interaction of genetic predisposition and environmentally induced oxidative injury.
引用
收藏
页码:1802 / 1808
页数:7
相关论文
共 48 条
[1]   INDUCTION OF CYTOCHROMES-P-450 IN PANCREATIC DISEASE - CONSEQUENCE, COINCIDENCE OR CAUSE [J].
ACHESON, DWK ;
ROSE, P ;
HOUSTON, JB ;
BRAGANZA, JM .
CLINICA CHIMICA ACTA, 1985, 153 (02) :73-84
[2]   Metabolic activation of aromatic amines by human pancreas [J].
Anderson, KE ;
Hammons, GJ ;
Kadlubar, FF ;
Potter, JD ;
Kaderlik, KR ;
Ilett, KF ;
Minchin, RF ;
Teitel, CH ;
Chou, HC ;
Martin, MV ;
Guengerich, FP ;
Barone, GW ;
Lang, NP ;
Peterson, LA .
CARCINOGENESIS, 1997, 18 (05) :1085-1092
[3]   Towards a novel treatment strategy for acute pancreatitis - 1. Reappraisal of the evidence on aetiogenesis [J].
Braganza, JM .
DIGESTION, 2001, 63 (02) :69-91
[4]   Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis [J].
Cohn, JA ;
Friedman, KJ ;
Noone, PG ;
Knowles, MR ;
Silverman, LM ;
Jowell, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (10) :653-658
[5]  
COMFORT MW, 1946, GASTROENTEROLOGY, V6, P239
[6]   AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma [J].
DiMagno, EP ;
Reber, HA ;
Tempero, MA .
GASTROENTEROLOGY, 1999, 117 (06) :1464-1484
[7]   Chronic pancreatitis: Diagnosis, classification, and new genetic developments [J].
Etemad, B ;
Whitcomb, DC .
GASTROENTEROLOGY, 2001, 120 (03) :682-707
[8]   OCCUPATION AND PANCREATIC-CANCER RISK IN LOUISIANA [J].
FALK, RT ;
PICKLE, LW ;
FONTHAM, ET ;
CORREA, P ;
MORSE, A ;
CHEN, V ;
FRAUMENI, JJ .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 1990, 18 (05) :565-576
[9]   INDUCTION OF DRUG-METABOLIZING-ENZYMES IN HUMAN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS [J].
FOSTER, JR ;
IDLE, JR ;
HARDWICK, JP ;
BARS, R ;
SCOTT, P ;
BRAGANZA, JM .
JOURNAL OF PATHOLOGY, 1993, 169 (04) :457-463
[10]  
GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97